Vranckx P, Halvorsen S(2025) Cracking the Clot: The RIVAWAR Trial Challenges Warfarin's Reign in Left Ventricular Thrombus Post-Acute Coronary Syndrome Eur Heart J Acute Cardiovasc Care(in press) DOI 10.1093/ehjacc/zuaf052, PubMed 40171935
Atar D, Vandenbriele C, Agewall S, Gigante B, Goette A, Gorog DA, Holme PA, Krychtiuk KA, Rocca B, Siller-Matula JM, Valgimigli M, Rubboli A, Klamroth R(2025) Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy Eur Heart J Cardiovasc Pharmacother(in press) DOI 10.1093/ehjcvp/pvaf006, PubMed 40145128
Alexander JH, Lydon EJ, Piccini JP, Viethen T, Oldgren J, Goodman SG, Steffel J, Russo AM, van Gelder IC, Ferdinand KC, Lopes RD, Mundl H, Benczur B, Gómez-Doblas JJ, Glikson M, Goudev A, Grove EL, Halvorsen S, Kiviniemi T, Martin AC, Sandhu RK, Vinereanu D, Rockhold FW, Caso V, Coppolecchia Ret al.(2025) Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical Trial JAMA Cardiol(in press) DOI 10.1001/jamacardio.2025.0277, PubMed 40136309
